6446.TW
Price:
$508
Market Cap:
$169.18B
PharmaEssentia Corporation, a biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally. Its products include Ropeginterferon alfa-2b that is used for the treatment of chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. The company also develops TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint abs for the treatment of solid tumors; P1101 + anti PD-1 for the treatment of hepatocellular carcinoma; and PEG-GCSF for the treatment of neutropenia. In addition, it focuses on the drug research and development programs in the areas of hematology, infectious disease, and oncology. PharmaEssen...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-03-11
Stock Exchange
TAI
Ticker
6446.TW
According to PharmaEssentia Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 43.68. This represents a change of -33.94% compared to the average of 66.12 of the last 4 quarters.
The mean historical PE Ratio of PharmaEssentia Corporation over the last ten years is -42.99. The current 43.68 PE Ratio has changed -10260.73% with respect to the historical average. Over the past ten years (40 quarters), 6446.TW's PE Ratio was at its highest in in the December 2023 quarter at 250.11. The PE Ratio was at its lowest in in the December 2022 quarter at -234.15.
Average
-42.99
Median
-35.49
Minimum
-180.67
Maximum
67.54
Discovering the peaks and valleys of PharmaEssentia Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 268.22%
Maximum Annual PE Ratio = 67.54
Minimum Annual Increase = -137.38%
Minimum Annual PE Ratio = -180.67
Year | PE Ratio | Change |
---|---|---|
2024 | 67.54 | -137.38% |
2023 | -180.67 | 83.22% |
2022 | -98.61 | 268.22% |
2021 | -26.78 | 129.58% |
2020 | -11.66 | -58.04% |
2019 | -27.80 | -21.48% |
2018 | -35.41 | -0.46% |
2017 | -35.57 | -8.90% |
2016 | -39.05 | -6.77% |
2015 | -41.88 | 40.24% |
The current PE Ratio of PharmaEssentia Corporation (6446.TW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-70.58
5-year avg
-50.04
10-year avg
-42.99
PharmaEssentia Corporation’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PharmaEssentia Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PharmaEssentia Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is PharmaEssentia Corporation's PE Ratio?
How is the PE Ratio calculated for PharmaEssentia Corporation (6446.TW)?
What is the highest PE Ratio for PharmaEssentia Corporation (6446.TW)?
What is the 3-year average PE Ratio for PharmaEssentia Corporation (6446.TW)?
What is the 5-year average PE Ratio for PharmaEssentia Corporation (6446.TW)?
How does the current PE Ratio for PharmaEssentia Corporation (6446.TW) compare to its historical average?